Coronavirus: the pharma and medtech response

The Statista dossier
  • Detailed references
  • Editorially prepared
  • Download as PDF / PPT

Statista dossier about the pharma and medtech response to the coronavirus pandemic

This dossier presents the response of the pharmaceutical and medical device industry to the COVID-19 pandemic. It is focused on some major aspects in relation to COVID-19: treatments, vaccines, diagnostics, and ventilators. There is also a chapter comparing biotechnology companies BioNTech and Moderna, the frontrunners in the race for the first coronavirus vaccine brought to market.

Table of contents

  • 1. Pharma - before the pandemic

    • Pharmaceutical market: worldwide revenue 2001-2020

    • Top global pharmaceutical companies based on pharma revenue 2019

    • Size of the global vaccine market by region 2014-2024

    • Leading pharmaceutical companies by global vaccine revenue 2019

    • Global anti-viral market size 2019 and 2027 forecast

    • Leading pharmaceutical companies by global anti-viral revenue 2017 and 2024

  • 2. Treatments and vaccines

    • Biotechs: duration of COVID-19 response compared to previous health threats 2003-2019

    • Number of registered COVID-19 studies worldwide Apr 2020 - Mar 2021, by region

    • Number of COVID-19 treatment vaccines in development worldwide by phase June 2021

    • Top companies by COVID-19 treatment vaccines in development June 2021

    • Number of COVID-19 treatment vaccine trials worldwide by phase June 2021

    • Number of COVID-19 treatment vaccine trials worldwide by type June 2021

    • Select COVID-19 vaccine pricing and funding as of August 2020

    • Gilead Science's remdesivir manufacturing projections 2020

    • Worldwide remdesivir sales forecast 2020-2026

  • 3. Focus: BioNTech and Moderna

    • COVID-19 vaccine comparison Biontech/Pfizer vs Moderna 2020

    • Revenue of BioNTech 2017-2020

    • Operating loss of BioNTech 2017-2020

    • Total assets of BioNTech 2017-2020

    • Moderna's revenue 2016-2020

    • R&D expenses of Moderna 2016-2020

    • R&D expenses of Moderna by type 2020

  • 4. Opinions on COVID-19 vaccines

    • U.S. adults who would get a coronavirus vaccine, Jan. 2020 to Jan. 2021

    • U.S. adults who would hypothetically get a coronavirus vaccine as of 2020, by gender

    • U.S. adults who would hypothetically get a coronavirus vaccine October 2020, by age

    • Share of Canadians who would get vaccinated for COVID Jul. 2020 - Mar. 2021

    • Willingness to wait before getting COVID-19 vaccine once available in Italy 2020

    • Brazil: people planning on getting immunized against COVID-19 2020

  • 5. Business impact

    • Market capitalization change in key COVID-19 firms until end-May 2020

    • Top challenges for pharmaceutical companies during COVID-19 2020

    • Launch disruption on global pharmaceutical market due to coronavirus 2020-2025

    • Covid-19 impact: global pharma specialty excipient demand CAGR 2019-2024

  • 6. Medtech - before the pandemic

    • Total medtech revenue worldwide 2011-2024

    • In-vitro diagnostics market revenues worldwide 2018-2027

    • Global in vitro diagnostics market share by top medtech companies 2017 and 2024

    • Global ventilator market size 2018-2026

    • Global ventilator market size by type 2018-2026

  • 7. Ventilators and testing

    • Number of COVID-19-related EUAs for ventilators developed by company May 2020

    • Respiratory devices with potential being modified to ventilators by company 2020

    • Weekly ventilator production change in U.S. due to COVID-19 until April 2020

    • Cumulative EUAs granted to COVID-19 tests March-November 2020

    • Accuracy figures for selected COVID-19 antibody tests sold in the US 2020

    • Number of COVID-19 tests carried out daily in U.S. March-November2020

    • Rate change of COVID-19 testing in select countries April-November 2020

Order dossier
More than 7,500
companies trust
Statista

Recommended studies and dossiers

Recent studies and dossiers

You may also be interested in...

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!

Contact
Esther Shaulova
Operations Manager
support@statista.com +1 (212) 419-5770

Mon - Fri, 9am - 6pm, EST

Contact (Europe)
Lodovica Biagi
Director of Operations
eu.support@statista.com +44 (0)20 8189 7000

Mon - Fri, 9:30am - 5pm, GMT

New

All Dossiers for free within the Project Account

Order a Project Account now to get immediate access to our dossiers, studies and reports.

Get Project Account
No Thanks, order dossier

Statista Project Account

  • Immediate access to dossiers, reports and studies
  • Unlimited access to statistics, Market Outlooks and forecasts
  • No subscription (30 days duration)

Download your Report

We value your privacy and will never rent or sell your email address.

Privacy

Menu